#literaturescreening

Drug safety operations are becoming increasingly complex, with growing case volumes, evolving regulatory expectations, and the demand for faster, more consistent assessments. Traditional manual processes often struggle to keep up leading to delayed signal detection, operational fatigue, and compliance risks.

This visual highlights the top four challenges faced by pharmacovigilance and drug safety teams, and how AI-powered solutions are transforming global workflows:

✅ Data Overload - Thousands of safety reports, literature data, and case documents overwhelm internal teams and slow decision-making. AI automates data ingestion and triage, helping prioritize high-risk cases instantly.

✅ Inconsistent Case Assessment - Manual review can introduce variability and contribute to missed signals. AI-driven case evaluation supports more consistent, pattern-based safety assessments.

✅ Slow Literature Screening - Full-text review is time-intensive and delays signal detection. NLP-enabled screening accelerates identification of relevant safety content in seconds.

✅ Resource Fatigue & Burnout - Labor-intensive manual tasks increase workload and contribute to operational burnout. Automation reduces human effort so safety experts can focus on strategic tasks.